LONDON (Alliance News) - Healthcare and life sciences company Arix Bioscience PLC on Thursday said that its Non-Executive Director James Hutton will step down immediately.
"It has been a great pleasure to work with Lord Hutton over the last two years, he has been an invaluable guide to me and to the board as we have built Arix Bioscience and we will all miss his wise counsel and support," said Chairman Jonathan Peacock.
Shares in Arix were trading 0.2% higher at 208.00 pence each on Thursday afternoon.


Arix Bioscience PLC - London-based venture capital firm focused on biotechnology companies - Shares suspended from the London Stock Exchange amid the ...


RTW Biotech Opportunities Ltd - New York-based investment firm focused on the life sciences sector - Says it completed on Friday its previously announ...


Arix Bioscience PLC - London-based venture capital firm focused on biotechnology companies - Shares suspended from the London Stock Exchange amid the ...


RTW Biotech Opportunities Ltd - New York-based investment firm focused on the life sciences sector - Says it completed on Friday its previously announ...


Arix Bioscience PLC - London-based venture capital firm investing in "breakthrough" biotechnology companies - Expects USD18.6 million net proceeds fro...


(Alliance News) - RTW Biotech Opportunities Ltd on Wednesday said it has agreed to acquire all the assets of fellow London listing Arix Bioscience PLC...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and Tuesday and not separat...


(Alliance News) - Arix Bioscience PLC on Wednesday said net asset value increased in its latest half year, but has since launched a strategic review d...